CN107137784A - Deep-sea fish collagen peptide hydrogel - Google Patents
Deep-sea fish collagen peptide hydrogel Download PDFInfo
- Publication number
- CN107137784A CN107137784A CN201710318213.2A CN201710318213A CN107137784A CN 107137784 A CN107137784 A CN 107137784A CN 201710318213 A CN201710318213 A CN 201710318213A CN 107137784 A CN107137784 A CN 107137784A
- Authority
- CN
- China
- Prior art keywords
- add
- stir
- collagen
- collagen peptide
- milliliters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 28
- 108010035532 Collagen Proteins 0.000 title claims abstract description 28
- 229920001436 collagen Polymers 0.000 title claims abstract description 28
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 26
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 11
- 239000000017 hydrogel Substances 0.000 title claims abstract description 8
- 238000003756 stirring Methods 0.000 claims abstract description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000000502 dialysis Methods 0.000 claims abstract description 5
- DCUFMVPCXCSVNP-UHFFFAOYSA-N methacrylic anhydride Chemical compound CC(=C)C(=O)OC(=O)C(C)=C DCUFMVPCXCSVNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000004321 preservation Methods 0.000 claims abstract 2
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000005847 immunogenicity Effects 0.000 abstract description 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 230000006862 enzymatic digestion Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 230000007547 defect Effects 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- -1 nitrogen-nitrogen-dimethylmethane Chemical compound 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明提供了一种深海鱼胶原蛋白肽水凝胶,其制备方法是:(1)、将3‑5克胶原蛋白肽粉溶于100毫升PBS缓冲液;(2)、调节pH值到6‑7.4;(3)、在100ml胶原蛋白肽溶液中加入30ml氮氮二甲基间酰胺,充分搅拌溶解;(4)、然后加入4‑5毫升三乙胺搅拌至充分溶解;(5)、再加入8‑10毫升甲基丙烯酸酐,搅拌过夜,至充分溶解;(6)、间断搅拌,反应3天;(7)、用1000道尔顿分子量大小透析袋透析三天,间断换水;(8)、将透析后的肽溶液置于皿中预冻;(9)、放入冻干机冻干;(10)、最后收集粉末保存;发明以鱼类提取为主,通过酸碱、酶切等技术把分子量控制在6000道尔顿以内的胶原蛋白肽,具有很好的溶解度和保水能力,以及低的免疫原性和生物可降解性。The invention provides a deep sea fish collagen peptide hydrogel, the preparation method of which is: (1), dissolving 3-5 grams of collagen peptide powder in 100 milliliters of PBS buffer; (2), adjusting the pH value to 6 ‑7.4; (3), add 30ml of nitrogen nitrogen dimethyl metamidamide to 100ml of collagen peptide solution, fully stir to dissolve; (4), then add 4‑5ml of triethylamine and stir until fully dissolved; (5), Then add 8-10 milliliters of methacrylic anhydride, stir overnight until fully dissolved; (6), stir intermittently, react for 3 days; (7), dialyze with a 1000 Dalton molecular weight dialysis bag for three days, and change the water intermittently; (8), pre-freeze the dialyzed peptide solution in a dish; (9), freeze-dry it in a lyophilizer; (10), finally collect the powder for preservation; the invention is mainly based on fish extraction, through acid-base, Collagen peptides whose molecular weight is controlled within 6000 Daltons by enzymatic digestion and other technologies have good solubility and water retention capacity, as well as low immunogenicity and biodegradability.
Description
技术领域technical field
本发明涉及的是水凝胶技术领域,具体的说是一种深海鱼胶原白肽水凝胶。The invention relates to the field of hydrogel technology, in particular to a deep-sea fish collagen white peptide hydrogel.
背景技术Background technique
皮肤是人体与环境间的天然屏障和沟通桥梁,大面积暴露于外部环境的皮肤组织,可能因为烧伤、机械创伤以及慢性疾病(如糖尿病)等造成缺损或功能丧失。我国每年各类皮肤缺损患者高达数千万,皮肤缺损治疗的关键在于尽早封闭创面,减少由于感染而导致的并发症。迄今为止,自体皮移植仍然是治疗全层皮肤缺损的最有效方法。对于大面积皮肤缺损患者,自体皮移植存在供皮区不足等问题,需要经过多次移植才能最终治愈。大面积全层皮肤缺损患者的高死亡率仍然是临床上亟待解决的难题之一。组织工程和再生医学的发展使皮肤缺损的完全再生和修复成为可能。皮肤组织工程的研究内容主要包括三个方面,即皮肤种子细胞培养、真皮支架材料和体外构建活性复合皮。Skin is a natural barrier and bridge between the human body and the environment. Skin tissue exposed to the external environment in large areas may be damaged or lose function due to burns, mechanical trauma, and chronic diseases (such as diabetes). There are tens of millions of patients with various skin defects every year in our country. The key to the treatment of skin defects is to seal the wound as soon as possible and reduce the complications caused by infection. So far, autologous skin grafting remains the most effective method for treating full-thickness skin defects. For patients with large skin defects, there are problems such as insufficient skin donor sites in autologous skin transplantation, and multiple transplants are required to finally heal. The high mortality rate of patients with large full-thickness skin defects is still one of the clinical problems to be solved urgently. The development of tissue engineering and regenerative medicine has made it possible to completely regenerate and repair skin defects. The research content of skin tissue engineering mainly includes three aspects, namely skin seed cell culture, dermal scaffold material and in vitro construction of active composite skin.
组织工程皮肤的关键环节之一是构建缺失皮肤的支架结构,动物组织来源的细胞外基质大分子由于其能够提供细胞生存的空间结构、组织相容性较理想并具有细胞附着的结合点等特点,是目前组织工程皮肤支架所采用的主要材料(Clark et al.,2007)。由于从动物提取的胶原蛋白在吸收率方面有一定的局限性,并且随着对疯牛病、口蹄疫和禽流感等高致病性传染病的恐惧,这种较为传统的方式近趋淘汰。美国食品和药品管理署(FDA)已限制并逐步禁止其临床使用。且胶原蛋白可细分为:大分子胶原蛋白和小分子胶原蛋白肽。平常我们食用的猪蹄的胶质,里面含有的胶原蛋白是大分子蛋白质,其分子量在30万道尔顿以上,并不能被人体直接吸收,并且吸收率很低。One of the key steps in tissue engineering skin is to construct the scaffold structure of missing skin. The extracellular matrix macromolecules derived from animal tissue can provide the spatial structure for cell survival, have ideal histocompatibility and have the characteristics of cell attachment points. , is currently the main material used in tissue engineering skin scaffolds (Clark et al., 2007). Due to the limited absorption rate of collagen extracted from animals, and the fear of highly pathogenic infectious diseases such as mad cow disease, foot-and-mouth disease and bird flu, this more traditional method is on the verge of becoming obsolete. The US Food and Drug Administration (FDA) has restricted and gradually banned its clinical use. And collagen can be subdivided into: macromolecular collagen and small molecular collagen peptides. The collagen in the trotters that we usually eat is a macromolecular protein with a molecular weight of more than 300,000 Daltons, which cannot be directly absorbed by the human body, and the absorption rate is very low.
发明内容Contents of the invention
本发明的目的在于针对现有技术的缺陷和不足,提供了一种深海鱼胶原白肽水凝胶,以鱼类提取为主,通过酸碱、酶切等技术把分子量控制在6000道尔顿以内的胶原蛋白肽,具有很好的溶解度和保水能力,以及低的免疫原性和生物可降解性。The purpose of the present invention is to address the defects and deficiencies of the prior art, and provide a deep-sea fish collagen white peptide hydrogel, which is mainly extracted from fish, and the molecular weight is controlled at 6000 Daltons by acid-base, enzyme cutting and other technologies Collagen peptides within have good solubility and water retention capacity, as well as low immunogenicity and biodegradability.
为实现上述目的,本发明采用的技术方案是:In order to achieve the above object, the technical scheme adopted in the present invention is:
一种深海鱼胶原白肽水凝胶,其制备方法是:A deep-sea fish collagen white peptide hydrogel, the preparation method of which is:
1、将3-5克胶原蛋白肽粉溶于100毫升PBS缓冲液;1. Dissolve 3-5 grams of collagen peptide powder in 100 ml of PBS buffer;
2、调节pH值到6-7.4;2. Adjust the pH value to 6-7.4;
3、在100ml胶原蛋白肽溶液中加入30ml氮氮二甲基间酰胺,充分搅拌溶解;3. Add 30ml of nitrogen-nitrogen-dimethylmethane to 100ml of collagen peptide solution, stir well to dissolve;
4、然后加入4-5毫升三乙胺搅拌至充分溶解;4. Then add 4-5 ml of triethylamine and stir until fully dissolved;
5、再加入8-10毫升甲基丙烯酸酐,搅拌过夜,至充分溶解;5. Add 8-10 ml of methacrylic anhydride and stir overnight until fully dissolved;
6、间断搅拌,反应3天;6. Stir intermittently and react for 3 days;
7、用1000道尔顿分子量大小透析袋透析三天,间断换水;7. Dialyze with a 1000 Dalton molecular weight dialysis bag for three days, changing the water intermittently;
8、将透析后的肽溶液置于皿中预冻;8. Pre-freeze the dialyzed peptide solution in a dish;
9、放入冻干机冻干;9. Freeze-dry in a freeze dryer;
10、最后收集粉末保存。10. Finally, collect the powder and save it.
本发明有益效果为:本发明以鱼类提取为主,通过酸碱、酶切等技术把分子量控制在6000道尔顿以内的胶原蛋白肽,具有很好的溶解度和保水能力,以及低的免疫原性和生物可降解性。The beneficial effects of the present invention are as follows: the present invention is mainly based on fish extraction, and the collagen peptide whose molecular weight is controlled within 6000 Daltons through acid-base, enzyme digestion and other technologies has good solubility and water retention capacity, and low immunity Originality and biodegradability.
具体实施方式detailed description
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合具体实施方式,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施方式仅用以解释本发明,并不用于限定本发明。In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, and are not intended to limit the present invention.
实施例:Example:
一种深海鱼胶原白肽水凝胶,其制备方法是:A deep-sea fish collagen white peptide hydrogel, the preparation method of which is:
1、将5克胶原蛋白肽粉溶于100毫升PBS缓冲液;1. Dissolve 5 grams of collagen peptide powder in 100 ml of PBS buffer;
2、调节pH值到7.4;2. Adjust the pH value to 7.4;
3、在100ml胶原蛋白肽溶液中加入30ml氮氮二甲基间酰胺,充分搅拌溶解;3. Add 30ml of nitrogen-nitrogen-dimethylmethane to 100ml of collagen peptide solution, stir well to dissolve;
4、然后加入5毫升三乙胺搅拌至充分溶解;4. Then add 5 ml of triethylamine and stir until fully dissolved;
5、再加入10毫升甲基丙烯酸酐,搅拌过夜,至充分溶解;5. Add 10 ml of methacrylic anhydride and stir overnight until fully dissolved;
6、间断搅拌,反应3天;6. Stir intermittently and react for 3 days;
7、用1000道尔顿分子量大小透析袋透析三天,间断换水;7. Dialyze with a 1000 Dalton molecular weight dialysis bag for three days, changing the water intermittently;
8、将透析后的肽溶液置于皿中预冻;8. Pre-freeze the dialyzed peptide solution in a dish;
9、放入冻干机冻干;9. Freeze-dry in a freeze dryer;
10、最后收集粉末保存。10. Finally, collect the powder and save it.
本具体实施方式的使用方法:The usage method of this embodiment:
1、用培养基配制百分之十五的胶原溶液;1. Prepare fifteen percent collagen solution with culture medium;
2、调节pH值至7.4;2. Adjust the pH value to 7.4;
3、过滤除菌;3. Sterilize by filtration;
4、消化细胞,加入培养基终止消化,离心收集;4. Digest cells, add medium to stop digestion, and collect by centrifugation;
5、用少量培养基重悬细胞;5. Resuspend the cells with a small amount of medium;
6、将少量密度细胞悬液加入肽溶液;6. Add a small amount of density cell suspension to the peptide solution;
7、每毫升加入10微升百分之10的I2959溶液;7. Add 10 microliters of 10% I2959 solution per milliliter;
8、迅速接种孔板,365纳米波长紫外照射10至20分钟即可。8. Quickly inoculate the well plate and irradiate with 365 nm wavelength ultraviolet light for 10 to 20 minutes.
本具体实施方式采用的胶原蛋白以鱼类提取为主,通过酸碱、酶切等技术把分子量控制在6000道尔顿以内的胶原蛋白,称之为胶原蛋白肽;胶原蛋白肽较大分子具有一定的溶解度和保水能力,以及低的免疫原性和生物可降解性,将是性能更优越的支架材料。The collagen used in this specific embodiment is mainly extracted from fish, and the collagen whose molecular weight is controlled within 6000 Daltons by techniques such as acid-base and enzymatic digestion is called collagen peptide; the larger molecule of collagen peptide has Certain solubility and water retention capacity, as well as low immunogenicity and biodegradability, will be scaffold materials with superior performance.
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。It will be apparent to those skilled in the art that the invention is not limited to the details of the above-described exemplary embodiments, but that the invention can be embodied in other specific forms without departing from the spirit or essential characteristics of the invention. Accordingly, the embodiments should be regarded in all points of view as exemplary and not restrictive, the scope of the invention being defined by the appended claims rather than the foregoing description, and it is therefore intended that the scope of the invention be defined by the appended claims rather than by the foregoing description. All changes within the meaning and range of equivalents of the elements are embraced in the present invention.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described according to implementation modes, not each implementation mode only includes an independent technical solution, and this description in the specification is only for clarity, and those skilled in the art should take the specification as a whole , the technical solutions in the various embodiments can also be properly combined to form other implementations that can be understood by those skilled in the art.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710318213.2A CN107137784A (en) | 2017-05-08 | 2017-05-08 | Deep-sea fish collagen peptide hydrogel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710318213.2A CN107137784A (en) | 2017-05-08 | 2017-05-08 | Deep-sea fish collagen peptide hydrogel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107137784A true CN107137784A (en) | 2017-09-08 |
Family
ID=59778700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710318213.2A Pending CN107137784A (en) | 2017-05-08 | 2017-05-08 | Deep-sea fish collagen peptide hydrogel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107137784A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110790950A (en) * | 2019-10-21 | 2020-02-14 | 南京理工大学 | Photo-crosslinking recombinant collagen hydrogel, preparation method and application thereof in 3D bioprinting |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102688181A (en) * | 2012-03-22 | 2012-09-26 | 浙江省海洋开发研究院 | Preparation method of medical squid-skin collagen oligopeptide gel |
| CA2848405A1 (en) * | 2011-09-16 | 2013-03-21 | Wake Forest University Health Sciences | Fabrication of gelatin hydrogel sheet for the transplantation of corneal endothelium |
| CN104031274A (en) * | 2014-05-28 | 2014-09-10 | 中国科学院烟台海岸带研究所 | Preparation method of aquatic fish skin collagen hydrogel |
| WO2014147415A1 (en) * | 2013-03-22 | 2014-09-25 | University Of Leeds | Improvements in and relating to collagen based materials |
| CN105936671A (en) * | 2016-06-06 | 2016-09-14 | 陕西科技大学 | Preparation method of vinyl collagen |
-
2017
- 2017-05-08 CN CN201710318213.2A patent/CN107137784A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2848405A1 (en) * | 2011-09-16 | 2013-03-21 | Wake Forest University Health Sciences | Fabrication of gelatin hydrogel sheet for the transplantation of corneal endothelium |
| CN102688181A (en) * | 2012-03-22 | 2012-09-26 | 浙江省海洋开发研究院 | Preparation method of medical squid-skin collagen oligopeptide gel |
| WO2014147415A1 (en) * | 2013-03-22 | 2014-09-25 | University Of Leeds | Improvements in and relating to collagen based materials |
| CN104031274A (en) * | 2014-05-28 | 2014-09-10 | 中国科学院烟台海岸带研究所 | Preparation method of aquatic fish skin collagen hydrogel |
| CN105936671A (en) * | 2016-06-06 | 2016-09-14 | 陕西科技大学 | Preparation method of vinyl collagen |
Non-Patent Citations (2)
| Title |
|---|
| GIUSEPPE TRONCI 等: "Multi-scale mechanical characterization of highly swollen photo-activated collagen hydrogels", 《OURNAL OF THE ROYAL SOCIETY INTERFACE》 * |
| 彭敏: "胶原蛋白肽接枝羧甲基纤维素及其衍生物制备及性能研究", 《中国优秀硕士学位论文全文数据库 工程科技I辑》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110790950A (en) * | 2019-10-21 | 2020-02-14 | 南京理工大学 | Photo-crosslinking recombinant collagen hydrogel, preparation method and application thereof in 3D bioprinting |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Novel decellularized liver matrix-alginate hybrid gel beads for the 3D culture of hepatocellular carcinoma cells | |
| CN103041383B (en) | Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method thereof | |
| EP2029727B1 (en) | Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof. | |
| TWI672155B (en) | Collagen sponge | |
| CN102726366B (en) | Organ preservation solution and method for preparing same | |
| RU2014121232A (en) | HEMOSTATIC COMPOSITIONS | |
| PT2184977T (en) | USE OF A GLOBIN, A GLOBIN PROTOMER OR AN EXTRACELLULAR HEMOGLOBIN FOR THE CONSERVATION OF ORGANS, TISSUES, OR ORGANS AND TISSUE CELLS | |
| CN102746372B (en) | Extracellular matrix freeze-drying protection liquid and application method thereof | |
| JP2002518319A (en) | Granular cell-free tissue matrix | |
| BR112017008117B1 (en) | biomaterial support to regenerate the oral mucosa | |
| CN106492285A (en) | Injectable Acellular cartilaginous matrix particulate and its application in implant | |
| WO2021159198A1 (en) | Method for producing decellularized biomaterial, decellularized biomaterial and use thereof | |
| PT87658B (en) | Process for the preparation of a solution with high specific volumic activity of a protein with a plasticizer activator activity of the tissues | |
| EP3134074B1 (en) | Compositions comprising cyclodextrin incorporated collagen matrices for use in biomedical applications | |
| CN110747176B (en) | Culture method for improving virus titer of porcine epidemic diarrhea viruses | |
| TW201623395A (en) | Chemical crosslinking composition, bio-medical material containing the same and use of the same | |
| CN107137784A (en) | Deep-sea fish collagen peptide hydrogel | |
| CN112602703A (en) | Preparation method and application of cold preservation solution for cells, tissues or organs | |
| JP2022551319A (en) | American cockroach extract, formulation, preparation method and use thereof | |
| TWI592421B (en) | Triple-crosslinked collagen, method of manufacture and use thereof | |
| CN106857499A (en) | Tea Polyphenols is used to prepare the application of pig semen preservation dilution with shitosan compatibility | |
| CN102091057B (en) | Preparation method of medicament-carrying biological membrane | |
| CN105532646B (en) | Liver cell preserves liquid and its preparation method and application | |
| WO2022178907A1 (en) | Use of polypeptide in promotion of cartilage regeneration or repair | |
| CN102168063A (en) | Method for separation and primary culture of intestinal mucosal cells of fishes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170908 |